3058127-20-8
Chemical Structure
Poterepatide
Synonym(s): HDM1005
- CAS No.: 3058127-20-8
- Formula:C243H382N52O73
- Molecular Weight:5199.94
SMILES: NCCCC[C@@H](C(N)=O)NC([C@H](CO)NC([C@H]1N(C([C@H]2N(C([C@H]3N(C([C@H](C)NC(CNC([C@H](CO)NC([C@H](CO)NC([C@H]4N(C(CNC(CNC([C@H](CCCCN)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC5=CNC6=C5C=CC=C6)NC([C@H](CCCCNC(COCCOCCNC(COCCOCCNC(COCCOCCNC(CC[C@@H](C(O)=O)NC(CCCCCCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)=O)=O)N(C([C@H](C)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CCC(N)=O)NC([C@H](CCCCN)NC([C@H](CC(O)=O)NC([C@H](CC(C)C)NC(C(C)(C)N(C([C@H](CC7=CC=C(O)C=C7)NC([C@H](CC(O)=O)NC([C@H](CO)NC([C@H]([C@H](O)C)NC([C@@](CC8=CC=CC=C8)(C)NC([C@H]([C@H](O)C)NC(CNC([C@H](CCC(O)=O)NC(C(C)(C)NC([C@H](CC9=CC=C(O)C=C9)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C([C@H]([C@@H](C)CC)NC(C(C)(C)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)C([C@H](C(C)C)NC([C@H](CC%10=CC=CC=C%10)NC([C@H](CCC(O)=O)N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCC4)=O)=O)=O)=O)=O)CCC3)=O)CCC2)=O)CCC1)=O)=O
Biological Activity: Poterepatide (HDM1005) is a long-acting GLP-1R/GIPR peptide dual agonist. Poterepatide exhibits potent activity on both GLP-1 and GIP receptors. Poterepatide can be used for the study of obesity and type 2 diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Poterepatide | 99.78% | Poterepatide (HDM1005) is a long-acting GLP-1R/GIPR peptide dual agonist. Poterepatide exhibits potent activity on both GLP-1 and GIP receptors. Poterepatide can be used for the study of obesity and type 2 diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
